Poland, Germany and Switzerland Home Parenteral Nutrition (HPN) and Home Enteral Nutrition (HEN) Market, By Product & Services (Product and Services), Care Type (Pre-Operative Care and Post-Operative Care), Patient Type (Neurology Problems, Cancer, Abnormal Bowel Function, Crohn's Disease, Gastroparesis, and Others), Distribution Channel (B2B Channel and B2C Channel) - Industry Trends and Forecast to 2031.
Poland, Germany and Switzerland Home Parenteral Nutrition (HPN) and Home Enteral Nutrition (HEN) Market Analysis and Insights
According to an article published by BMC, in Poland, between 2015 and 2019, the prevalence of prostate cancer increased, with significant disparities observed between subregions with the lowest and highest incidence rates. In 2021, there was a marked disproportionate rise in cancer incidence rates. As more individuals are diagnosed with cancer, the demand for specialized long-term nutritional support to manage their health and improve treatment outcomes will increase, leading to an expansion of these markets.
Data Bridge Market Research analyzes that the Poland, Germany and Switzerland Home Parenteral Nutrition (HPN) and Home Enteral Nutrition (HEN) market is expected to reach USD 615.21 million by 2031 from USD 458.50 million in 2023, growing at a CAGR of 4.1% in the forecast period of 2024 to 2031.
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016–2021)
|
|
Quantitative Units
|
Revenue in USD Million
|
|
Segments Covered
|
Product & Services (Product and Services), Care Type (Pre-Operative Care and Post-Operative Care), Patient Type (Neurology Problems, Cancer, Abnormal Bowel Function, Crohn's Disease, Gastroparesis, and Others), Distribution Channel (B2B Channel and B2C Channel)
|
|
Countries Covered
|
Germany, Switzerland, and Poland
|
|
Market Players Covered
|
Fresenius SE & Co. KGaA, Nestlé, Abbott, B. Braun SE, Baxter, CSL, Nutricia, Pfizer Inc. and others
|
Market Definition
Home enteral nutrition is primarily for patients in whom there is a reduction in oral intake below the amount needed to maintain nutrition or hydration (i.e., oral failure), whereas home parenteral nutrition is used for patients when oral-enteral nutrition is temporarily or permanently impossible or absorption insufficient to maintain nutrition or hydration (i.e., intestinal failure). The development of home delivery of these therapies has revolutionized the field of clinical nutrition.
Poland, Germany and Switzerland Home Parenteral Nutrition (HPN) and Home Enteral Nutrition (HEN) Market Dynamics
This section deals with understanding the market drivers, opportunities, restraints, and challenges. All of this is discussed in detail below:
Driver
- Growing Aging Population
The aging populations in Poland, Germany and Switzerland are significantly driving the Home Parenteral Nutrition (HPN) and Home Enteral Nutrition (HEN) markets. In Poland, the demographic shift is resulting in a higher prevalence of chronic illnesses such as diabetes, cardiovascular diseases, and cancer, which often require long-term nutritional support. Elderly patients frequently struggle with nutrient intake due to swallowing difficulties and gastrointestinal disorders, increasing the demand for HEN and HPN. These therapies provide continuous, personalized care at home, enhancing quality of life and reducing hospital readmissions.
Restraint
- Lack of Awareness about Malnutrition
Malnutrition can lead to serious health issues, including stunted growth, eye problems, diabetes, and heart diseases. Moreover, malnutrition affects independence and the inability to be active. The lacks of awareness regarding the severe consequences of malnutrition, including death and severe health problems for patients, serves as a significant restraint for the growth of the home parenteral and enteral nutrition market. Malnutrition can lead to weakened immune systems, prolonged hospital stays, and increased healthcare costs. Despite its critical role in patient recovery and well-being, the understanding among both healthcare providers and the general public about the importance of adequate nutrition remains insufficient. This lack of awareness translates into delayed or inadequate referrals for nutrition support, underutilization of home nutrition therapies, and challenges in obtaining timely access to specialized nutritional care. Moreover, misconceptions or limited education about the benefits of home-based nutrition solutions further hinder adoption rates among patients who could benefit from these therapies.
Opportunity
- Adopting Digital Health Solutions
Adopting digital health solutions in the Home Parenteral Nutrition and Home Enteral Nutrition market offers the opportunity to revolutionize patient care by enhancing monitoring, communication, and treatment adherence. Leveraging telehealth platforms, mobile apps, and wearable devices enables real-time remote monitoring of patient vitals, nutritional intake, and treatment progress. By empowering patients to actively engage in their care and facilitating seamless communication with healthcare providers, digital health solutions improve patient outcomes, increase treatment adherence, and drive efficiency in home-based nutritional therapy.
Challenge
- Technical Requirements Restricts the Prevalence of Therapy
The technical needs requirements for Home Parenteral Nutrition (HPN) and Home Enteral Nutrition (HEN) make it tough for this markets to grow. From the surgical procedures, complicated and expensive equipment to the requirement for specialized training and knowledge in using them by caregivers and requirement for evaluation, along with dealing with rules, making different systems work together, and handling patient data carefully. So, these technical demands collectively hinder accessibility, affordability, and adoption of HPN and HEN therapies. All these factors make it harder for people to access and afford HPN and HEN to make these treatments more widely available, we need simpler solutions, easier rules, better training, and ways to keep patient information safe.
Recent Developments
- In January 2024, Abbott, a one of global leader in science-based nutrition, stated today the launch of its new PROTALITY brand. The high-protein nutrition shake is the first product in this line to support the growing number of adults interested in following weight loss while maintaining muscle mass and good nutrition.
- In October 2023, Nestlé announced a collaboration with Amwell to enhance patient outcomes through digital nutrition solutions. Their first initiative, the Advanced Surgical Nutrition Automated Care Program, combined Amwell’s virtual technology with Nestlé’s Impact ADVANCED RECOVERY drink to support surgical recovery. This collaboration benefited Nestlé by strengthening its position in the Home Enteral Nutrition (HEN) market, showcasing their commitment to integrating nutrition and technology to improve clinical outcomes
- In February 2022, Nestlé supported Feeding Tube Awareness Week from February 7th to 11th, 2022, to highlight the benefits of feeding tubes as life-saving interventions. The company shared information about their medical nutrition products, including nutritional supplements, tube feeds, and food thickeners. This initiative raised awareness about tube feeding and the importance of medical nutrition, benefiting Nestlé Health Science by showcasing their expertise and commitment to improving patient care. Through this effort, they strengthened their relationship with healthcare professionals and the public
- In June 2022, Upstream Rehabilitation Acquires Crescent Physical Therapy in South Carolina. Chris Kilgus fulfilled his goal of bringing outpatient physical therapy services back to his hometown of Orangeburg, S.C.
Poland, Germany and Switzerland Home Parenteral Nutrition (HPN) and Home Enteral Nutrition (HEN) Market Scope
Poland, Germany and Switzerland Home Parenteral Nutrition (HPN) and Home Enteral Nutrition (HEN) Market is segmented into four notable segments based on product & services, care type, patient type, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the differences in your target markets.
Product and Services
- Product
- Services
On the basis of product and services, the Poland, Germany and Switzerland Home Parenteral Nutrition (HPN) and Home Enteral Nutrition (HEN) market is segmented into product and services.
Care Type
- Pre-Operative Care
- Post-Operative Care
On the basis of care type, the Poland, Germany and Switzerland Home Parenteral Nutrition (HPN) and Home Enteral Nutrition (HEN) market is segmented into pre-operative care and post-operative care.
Patient Type
- Neurology Problems
- Cancer
- Abnormal Bowel Function
- Crohn's Disease
- Gastroparesis
- Others
On the basis of patient type, the Poland, Germany and Switzerland Home Parenteral Nutrition (HPN) and Home Enteral Nutrition (HEN) market is segmented into neurology problems, cancer, abnormal bowel function, crohn's disease, gastroparesis, others.
Distribution Channel
- B2B channel
- B2C channel
On the basis of distribution channel, the Poland, Germany and Switzerland Home Parenteral Nutrition (HPN) and Home Enteral Nutrition (HEN) market is segmented into B2B channel and B2C channel.
Poland, Germany and Switzerland Home Parenteral Nutrition (HPN) and Home Enteral Nutrition (HEN) Market Regional Analysis/Insights
The Poland, Germany and Switzerland Home Parenteral Nutrition (HPN) and Home Enteral Nutrition (HEN) market is segmented into four notable segments based on product & services, care type, patient type, and distribution channel.
The countries covered in this Poland, Germany and Switzerland Home Parenteral Nutrition (HPN) and Home Enteral Nutrition (HEN) market report are Germany, Switzerland, Poland.
Germany is expected to dominate the Poland, Germany and Switzerland Home Parenteral Nutrition (HPN) and Home Enteral Nutrition (HEN) market, owing to high number of people suffering from chronic diseases in Germany.
The country section of the report also provides individual market-impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of large services company and their challenges faced due to large or scarce competition from local and domestic players and the impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Poland, Germany and Switzerland Home Parenteral Nutrition (HPN) and Home Enteral Nutrition (HEN) Market Share Analysis
The Poland, Germany and Switzerland Home Parenteral Nutrition (HPN) and Home Enteral Nutrition (HEN) market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product approvals, product width and breadth, application dominance, and product type lifeline curve. The above data points provided are only related to the company’s focus on the market.
Some of the major market players operating in the market are Fresenius SE & Co. KGaA, Nestlé, Abbott, B. Braun SE, Baxter, CSL, Nutricia, Pfizer Inc. and others.
SKU-